pharmaphorum
JANUARY 27, 2022
Walter Greenleaf, PhD, neuroscientist and digital health expert at Stanford University’s Virtual Human Interaction Lab, tells us about the new book Applied Virtual Reality in Healthcare: Case Studies and Perspectives and why he and his co-authors gathered insights from some of the most prominent figures in the field of medical extended reality (XR).
Fierce Healthcare
JANUARY 27, 2022
MDLive rolls out virtual-first health monitoring program for chronic conditions. rtorrence. Thu, 01/27/2022 - 10:59.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JANUARY 27, 2022
The first patient has been treated with an implantable bioelectronic device developed by Galvani Therapeutics, set up by GlaxoSmithKline and Alphabet’s Verily Life Sciences in 2016. A rheumatoid arthritis patient has become the first of five to be implanted with the wireless device in the UK study – using keyhole surgery at the NHS Greater Glasgow & Clyde Health Board in Scotland last November – in a first step towards treating chronic diseases by modifying nerve signals to organs in t
Fierce Healthcare
JANUARY 27, 2022
Chutes & Ladders—North Carolina HHS head joins Aledade; Uber Health adds first-ever chief medical officer. dmuoio. Thu, 01/27/2022 - 16:27.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
pharmaphorum
JANUARY 27, 2022
Akili Interactive has agreed a merger with special purpose acquisition company (SPAC) Social Capital Suvretta Holdings Corp I in a deal that will take it into public hands with a valuation of around $1 billion. The digital health company, which developed the first prescription gaming app to be approved by the FDA, will swell its coffers by more than $410 million gross once the deal go through.
Fierce Healthcare
JANUARY 27, 2022
GAO calls for major reforms at HHS to better prepare for future health emergencies. rking. Thu, 01/27/2022 - 16:39.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Fierce Healthcare
JANUARY 27, 2022
HCA Healthcare's Q4 revenue dips under omicron's weight. dmuoio. Thu, 01/27/2022 - 11:41.
pharmaphorum
JANUARY 27, 2022
Biogen and Eisai have increased the earning potential of their Alzheimer’s drug Aduhelm by expanding the post-marketing trial of the drug required by the FDA – which could be the primary source of income for the drug. If the provisional reimbursement decision by the Centre for Medicare and Medicaid Services (CMS) is finalised, Aduhelm (aducanumab) will only be covered for certain patients enrolled in clinical trials.
Fierce Healthcare
JANUARY 27, 2022
SoftBank leads Alto Pharmacy's $200M series E as prescription delivery unicorn doubles annual revenue. rtorrence. Thu, 01/27/2022 - 14:34.
pharmaphorum
JANUARY 27, 2022
Paul Stoffels’ retirement at the end of last year after nine years as head of R&D at Johnson & Johnson was short lived – he’s just been named chef executive of Galapagos. Stoffels will take the helm of the troubled Belgian biotech on 1 April, when Galapagos’ long-serving CEO and co-founder Onno van de Stolpe starts his own retirement after 22 years at the company.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharma Marketing Network
JANUARY 27, 2022
In partnership with Villanova University, Drexel University, Thomas Jefferson University, the University of the Sciences and Columbia Business School, the HBA continues to advocate for the connection between advanced education and advancement in the workplace. For Immediate Release: Philadelphia— January 18, 2022 — Today, the Mid-Atlantic Region and the Philadelphia Chapter of the Healthcare Businesswomen’s Association announced the curriculum for their Winter 2022 Master Class, a series of 5 on
pharmaphorum
JANUARY 27, 2022
Andy Graves and Dr Clare Moloney of IQVIA discuss how the COVID-19 pandemic accelerated the adoption of digital patient services and how future deployment alongside traditional methods could offer the best of both approaches. They outline how the momentum developed in the utilisation of digital solutions during this period can be built on to create meaningful patient services.
Pharma Marketing Network
JANUARY 27, 2022
In partnership with Villanova University, Drexel University, Thomas Jefferson University, the University of the Sciences and Columbia Business School, the HBA continues to advocate for the connection between advanced education and advancement in the workplace. For Immediate Release: Philadelphia— January 18, 2022 — Today, the Mid-Atlantic Region and the Philadelphia Chapter of the Healthcare Businesswomen’s Association announced the curriculum for their Winter 2022 Master Class, a series of 5 on
pharmaphorum
JANUARY 27, 2022
Embrace Technology Innovations to Optimise LNP Formulation, Alternative LNP Raw Materials, Process Control to Achieve Seamless Scale-Up, Compliance & Cost Effectiveness . The inaugural LNP Formulation & Process Development Summit is the industry’s first forum dedicated to bringing together drug developers within the LNP field to share the latest scientific breakthroughs on formulation and process development.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Healthcare
JANUARY 27, 2022
In panel on climate health equity, experts share ways to help those most in need. agliadkovskaya. Thu, 01/27/2022 - 11:21.
Pharma Times
JANUARY 27, 2022
MHRA awards a positive scientific opinion for voxelotor–a once-daily tablet for the treatment of haemolytic anaemia
Fierce Healthcare
JANUARY 27, 2022
ACA signups reach record-breaking 14.5M thanks to enhanced subsidies, greater outreach. rking. Thu, 01/27/2022 - 11:01.
Pharma Times
JANUARY 27, 2022
Ground-breaking trial run by Oxford University has recruited 5000 people and will focus on severe COVID-19 symptoms
Fierce Healthcare
JANUARY 27, 2022
In panel on climate health equity, experts share ways to help those most in need. agliadkovskaya. Thu, 01/27/2022 - 11:26.
pharmaphorum
JANUARY 27, 2022
Moderna has started human trials of an Omicron version of its COVID-19 vaccine SpikeVax, just in case a modified version will be needed to boost protection against the new variant later this year. The biotech has also reported new data suggesting that may well be the case, with a six-fold reduction in neutralising antibody levels against the variant six months after a third dose of the current SpikeVax shot.
Expert insights. Personalized for you.
137 
Let's personalize your content